Previous studies show that genetic variation within the proline dehydrogenase gene (PRODH) increases risk of developing schizophrenia. This is of particular interest since PRODH maps to chromosome 22q11, deletion of which is a strong risk factor for schizophrenia. The authors examined this claim using samples with power of B0.99, but failed to obtain evidence in support of the hypothesis. Given the high power to replicate the previous findings, the data suggest that genetic variation in PRODH is unlikely to be associated with increased risk of schizophrenia.
There is consistent evidence indicating that predisposition to suicidal behavior is partly conferred by genes. The genes most commonly investigated in studies of suicidal behavior have been those that relate to the serotonin system. Serotonin, a molecule involved in the communication between neurons, appears to be altered in suicidal patients. In this article, the authors conducted a systematic review and meta-analyses of the studies investigating serotonin genes in suicide. The results suggest that the gene that codes for serotonin transporter may play a role in the predisposition to suicide.
LILLY-MOLECULAR PSYCHIATRY AWARD, WINNER
b-1,3-Glucuronyltransferase-1 gene implicated as a candidate for a schizophrenia-like psychosis through molocular analysis of a balanced translocation AR Jeffries, AJ Mungall, E Dawson, K Halls, CF Langford, RM Murray, I Dunham, JF Powell This report describes the molecular genetic characterization of a balanced chromosome translocation cosegregation with a schizophrenia-like psychosis in a three-generation pedigree. Both chromosome breakpoints were sequenced showing no direct disruption of any genes. However, a small number of genes close to the breakpoints may have altered gene expression due to the chromosomal rearrangement. The gene B3GAT1 or b-1,3-glucuronyltransferase-1 close to the chromosome 11 breakpoint is the most likely candidate for the psychosis in this family and may also be a risk factor in the general population. Mice lacking the adrenergic receptor a1d subtype show normal growth and development but display a number of behavioral phenotypes associated with stimulus-induced locomotor activity. The data presented here indicate that a1d receptors are required for facilitating selective attention and subsequent behavioral responses to environmental cues. The development of a1d subtype selective agonists may have therapeutic value in the treatment of generalized attention-deficit disorders.
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Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice ET Tzavara, FP Bymaster, CC Felder, M Wade, J Gomeza, J Wess, DL McKinzie, GG Nomikos Using muscarinic M2 and M4 receptor knockout (KO) as well as double M2/M4 receptor KO mice, the authers found profound alterations in basal acetylcholine release in M4-and M2/M4-KO and it evoked acetylcholine release in M2-and M2/M4-KO mice. M2-and M2/M4-KO mice, but not M4-KO animals, showed impaired performance in a cognitive task. This study revealed a crucial role for M2 and M4 receptors in the regulation of acetylcholine release in the hippocampus as well as for M2 receptors in cognitive processes.
Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa P Monteleone, A Di Lieto, V Martiadis, M Pannuto, M Maj It has been estimated that about 80% of all knoun harmones and neurotransmitters elicit cellular responses through G proteins. Therefore, it seems likely that both qualitative and quantitative dysfunction of proteins may lead to alterd CNS functions and disturbed behaviors. The authors found that patients with anorexia nervosa or bulimia nervosa exhibit increased levels of some G protein subunits in peripheral blood cells. These results may suggest a derangement of G protein-mediated signal transduction in the pathophysiology of eating disorders.
Disrupted-in-schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth K Miyoshi, A Honda, K Baba, M Taniguchi, K Oono, T Fujita, S Kuroda, T Katayama, M Tohyama Schizophrenia is a debilitating mental disease that affects about 1% of the population. The pathogenic mechanisms leading to the disease have not been established. The authors show that DISC1, disruption of which segregated with schizophrenia in a Scottish family, participates in neurite outgrowth through its interaction with a protein involved in axonal outgrowth. The results suggest that elucidation of the pathophysiological role of DISC1 will provide a better understanding of the general etiology of schizophrenia.
Genome-wide scan in a large complex pedigree with predominantly male schizophrenics from the island of Kosrae: evidence for linkage to chromosome 2q EM Wijsman, EA Rosenthal, D Hall, ML Blundell, C Sobin, SC Heath, R Williams, MJ Brownstein, JA Gogos, M Karayiorgou
The unique demographic history of the Kosraen islandic population in Micronesia could offer the potential for reduced heterogeneity, as well as the opportunity to identify extended pedigrees. A genome-wide scan, using 32 patients ascertained from the island, provided evidence for linkage to schizophrenia with markers on chromosomes 1, 2, 3, 7, 13, 15, 19, and X. Follow-up analyses gave additional support for 2q37, a region also implicated in another small genetic isolate on the eastern border of Finland. In 8p22-p12, the candidate gene neuregulin 1 (NRG1) may play a role in the pathogenesis of schizophrenia. In the present study, the authors performed the linkage disequilibrium to determine the association between three genetic variants (rs3924999, rs2954041, SNP8NRG221533) on NRG1 gene and schizophrenia in 246 Chinese Han schizophrenic family trios. PCRbased, restriction fragment length polymorphism method and denaturing high-performance liquid chromatography were used. The results suggest that the NRG1 gene may play a role in conferring susceptibility to the disease.
